TBPH
NASDAQ
$15.92
Theravance Biopharma Inc (TBPH)
Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and markets organ-selective drugs in the United States, Europe, and Asia. The company is headquartered in George Town, the Cayman Islands.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $17.40 (+9.30%)
Market Cap
$838M
Forward P/E
7.45
P/E Ratio
11.78
Free Cash Flow Yield
32.09%
Price Chart
Valuation
Market Cap$838M
P/E11.78
Forward P/E7.45
P/S7.64
P/B2.88
Profitability
Total Revenue (TTM)$110M
Gross Profit (TTM)$78M
EBITDA$4.92M
Profit Margin-27.9%
Operating Margin-53.6%
EPS$1.38
Financial Health
Free Cash Flow Yield32.09%
Growth & Risk
Revenue 5Y CAGR+10.63%
Beta (5Y)0.58
Sharpe Ratio1.22